BWAY vs. CBLL, BBNX, AVNS, IRMD, BFLY, SIBN, KIDS, TMCI, DCTH, and CLPT
Should you be buying BrainsWay stock or one of its competitors? The main competitors of BrainsWay include CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Iradimed (IRMD), Butterfly Network (BFLY), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry.
BrainsWay vs.
BrainsWay (NASDAQ:BWAY) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.
In the previous week, BrainsWay and BrainsWay both had 2 articles in the media. CeriBell's average media sentiment score of 1.48 beat BrainsWay's score of -0.89 indicating that CeriBell is being referred to more favorably in the news media.
CeriBell has higher revenue and earnings than BrainsWay.
BrainsWay has a net margin of 3.88% compared to CeriBell's net margin of 0.00%. BrainsWay's return on equity of 3.52% beat CeriBell's return on equity.
BrainsWay presently has a consensus target price of $13.17, suggesting a potential upside of 36.16%. CeriBell has a consensus target price of $32.60, suggesting a potential upside of 61.71%. Given CeriBell's higher possible upside, analysts plainly believe CeriBell is more favorable than BrainsWay.
BrainsWay received 61 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 67.31% of users gave BrainsWay an outperform vote.
30.1% of BrainsWay shares are held by institutional investors. 19.0% of BrainsWay shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
BrainsWay and CeriBell tied by winning 6 of the 12 factors compared between the two stocks.
Get BrainsWay News Delivered to You Automatically
Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BrainsWay Competitors List
Related Companies and Tools
This page (NASDAQ:BWAY) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy BWAY Stock Free BWAY Stock Alerts